Category

UCI MIND

FDA Advisory Panel Meeting Held To Consider Potential Approval Of Donanemab

By Blog, In the News, UCI MIND No Comments
The U.S. Food and Drug Administration. On 6/10/24, the FDA convened its Peripheral and Central Nervous System Drugs Advisory Committee to review the data from pivotal clinical trials of donanemab, one of which was conducted at UCI MIND. Click to read the full commentary about an FDA-convened advisory panel’s recommendations related to donanemab written by UCI MIND director, Dr. Joshua Grill or visit UCI MIND blog.
Read More

Annual Symposium Research Highlights and Congratulations to Marina Ritchie!

By In the News, UCI MIND No Comments
On Wednesday, March 13, 2024, the trainee led Research and Education in Memory Impairments and Neurological Disorders (REMIND) held it's 15th annual Emerging Scientists Symposium. Marina Ritchie, a graduate student in the Grill Lab and Jean Paul Chadarevian, a postdoctoral scholar in the Blurton-Jones Lab, were recognized this year with the Carl W. Cotman Scholar Awards, given to trainees for their achievements in brain aging research at UCI.
Read More